Reducing the immunogenicity of fusion proteins

Details for Australian Patent Application No. 2002306976 (hide)

Owner Merck Patent GmbH

Inventors Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2002306976

PCT Number PCT/US02/09815

PCT Pub. Number WO2002/079232

Priority 60/280,625 30.03.01 US

Filing date 30 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 3 January 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

C07K 14/76 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/280,625 30.03.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002306976

3 January 2008 Application Accepted

  Published as AU-B-2002306976

1 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306977-Power control for point-to-multipoint services provided in communication systems

2002306975-CANCER-TESTIS ANTIGENS